There are many different patch types studies used for assessing the safety of topical products. ALS is a leading source of shared human repeat insult patch tests (HRIPT), as well as primary irritation, and cumulative irritation tests. Whether you are looking for simple safety test on 50 subjects, or an FDA filing requiring 200, ALS is ready to assist you.
ALS has multiple sites for conducting our shared HRIPT panels located in the USA and Latin America that allow us to build a robust recruitment pipeline and insulate our clients from pandemic related delays. ALS has the most organized reporting system, allowing us to issue reports within three days of the competition of our panels, where competitors take several weeks.
No, if you can provide the ingredient list and usage instructions ALS experts can determine what patch is correct for your sample.